Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

INKTMiNK Therapeutics, Inc.

Nasdaq · CIK 0001840229
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts166

Identity from submissions API

NameMiNK Therapeutics, Inc.
CIK0001840229
TickersINKT
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone212-994-8250
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • AgenTus Therapeutics, Inc. (2021-03-17T04:00:00.000Z → 2021-03-18T04:00:00.000Z)
  • AgenTus Therapeutics, Inc. (2021-03-17T04:00:00.000Z → 2021-03-18T04:00:00.000Z)
Business address
149 FIFTH AVENUE
SUITE 500
NEW YORK
NY
10010
NY
Mailing address
149 FIFTH AVENUE
SUITE 500
NEW YORK
NY
10010
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

267 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 10-Q 10-Q 0001193125-26-457280 001-40908 261544400 34 6336988 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-457244 001-40908 261544268 34 256361 1 1
2026-10-14 4 4 0001193125-26-421529 9490
2026-10-13 144 xsl144X01/primary_doc.xml 0001973379-26-000350 001-40908 261454848 33 4660
2026-09-02 4 4 0001193125-26-379575 5787
2026-09-02 4 4 0001193125-26-379524 4959
2026-09-02 4 4 0001193125-26-379522 4930
2026-09-02 4 4 0001193125-26-379518 4929
2026-09-02 4 4 0001193125-26-379513 4978
2026-08-13 S-8 S-8 0001193125-26-349328 333-298308 261274055 33 217753 1 1
2026-08-13 10-Q 10-Q 0001193125-26-349309 001-40908 261274040 34 5480376 1 1
2026-08-13 8-K 8-K 2.02 0001193125-26-347907 001-40908 261270091 34 215849 1 1
2026-06-23 8-K 8-K 5.07 0001193125-26-278642 001-40908 261109403 34 165780 1 1
2026-06-05 4 4 0001193125-26-260084 6233
2026-06-02 4 4 0001193125-26-253474 6513
2026-06-02 4 4 0001193125-26-253470 6484
2026-06-02 4 4 0001193125-26-253468 6533
2026-06-02 4 4 0001193125-26-253466 6485
2026-06-02 4 4 0001193125-26-253461 7284
2026-05-15 10-Q 10-Q 0001193125-26-226804 001-40908 26987837 34 4864470 1 1
2026-05-15 8-K 8-K 2.02,9.01 0001193125-26-225369 001-40908 26982400 34 352456 1 1
2026-04-30 ARS ARS 0001193125-26-197583 001-40908 26926394 34 1269049
2026-04-30 DEF 14A DEF 14A 0001193125-26-197577 001-40908 26926372 34 1648008
2026-04-30 4 4 0001193125-26-197482 5617
2026-04-09 3 3 0001193125-26-149642 3900
2026-03-31 10-K 10-K 0001193125-26-134813 001-40908 26822944 34 8312250 1 1
2026-03-31 8-K 8-K 2.02,9.01 0001193125-26-133346 001-40908 26817136 34 388458 1 1
2026-03-27 8-K 8-K 8.01 0001193125-26-127931 001-40908 26802306 34 151185 1 1
2026-03-23 3 3 0001193125-26-119823 3780
2026-03-19 8-K 8-K 5.02 0001193125-26-116219 001-40908 26775257 34 158205 1 1
2026-03-11 4 4 0001193125-26-102581 8904
2026-03-04 4 4 0001193125-26-091707 5766
2026-01-14 4/A 4/A 0001193125-26-012914 5085
2026-01-06 4 4 0001193125-26-004799 7361
2026-01-06 4 4 0001193125-26-004786 5139
2026-01-06 4 4 0001193125-26-004779 5228
2026-01-06 4 4 0001193125-26-004776 5280
2026-01-06 4 4 0001193125-26-004769 5229
2026-01-02 8-K 8-K 5.02 0001193125-26-000916 001-40908 26502384 34 150277 1 1
2025-12-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003665 333-291388 251566468 33 1870
2025-12-10 CORRESP filename1.htm 0001193125-25-314317 7893
2025-12-10 S-3/A S-3/A 0001193125-25-314252 333-291388 251562294 33 708126 1 1
2025-12-08 8-K 8-K 2.02,9.01 0001193125-25-311229 001-40908 251556209 34 515503 1 1
2025-12-03 4 4 0001193125-25-306681 4843
2025-12-03 4 4 0001193125-25-306680 4795
2025-12-03 4 4 0001193125-25-306678 4794
2025-12-03 4 4 0001193125-25-306679 4824
2025-12-03 4 4 0001193125-25-306676 4833
2025-12-03 4 4 0001193125-25-306675 5594
2025-11-14 10-Q 10-Q 0001193125-25-282905 001-40908 251485865 34 5740066 1 1
2025-11-07 S-3 S-3 0001193125-25-272532 333-291388 251463414 33 715149 1 1
2025-10-03 4/A 4/A 0001193125-25-230098 5088
2025-09-29 8-K 8-K 5.02,9.01 0001193125-25-221863 001-40908 251352552 34 173310 1 1
2025-09-11 4 4 0001193125-25-201376 7473
2025-09-11 4 4 0001193125-25-201318 5311
2025-09-11 4 4 0001193125-25-201317 5273
2025-09-11 4 4 0001193125-25-201315 5321
2025-09-11 4 4 0001193125-25-201314 5180
2025-09-11 4 4 0001193125-25-201313 5272
2025-09-03 4 4 0001193125-25-195095 5594
2025-09-03 4 4 0001193125-25-195091 4832
2025-09-03 4 4 0001193125-25-195090 4794
2025-09-03 4 4 0000950170-25-112884 4843
2025-09-03 4 4 0000950170-25-112882 4795
2025-08-29 144 xsl144X01/primary_doc.xml 0000950170-25-112266 001-40908 251281828 33 5661
2025-08-22 424B5 424B5 0001193125-25-186417 333-268143 251246277 33 14728
2025-08-14 S-8 S-8 0001193125-25-180815 333-289606 251219828 33 204791 1 1
2025-08-14 10-Q 10-Q 0000950170-25-108894 001-40908 251219476 34 5401706 1 1
2025-08-14 8-K FORM 8-K 2.02,9.01 0001171843-25-005405 001-40908 251214365 34 245795 1 1
2025-07-15 8-K 8-K 1.01,9.01 0001193125-25-159017 001-40908 251123057 34 407965 1 1
2025-07-15 424B5 424B5 0001193125-25-159014 333-268143 251123053 33 421019
2025-07-14 8-K 8-K 8.01 0000950170-25-095460 001-40908 251120156 34 158193 1 1
2025-06-18 8-K 8-K 5.07 0000950170-25-087888 001-40908 251057011 34 168798 1 1
2025-06-04 4 4 0000950170-25-081610 4842
2025-06-04 4 4 0000950170-25-081612 4794
2025-06-04 4 4 0000950170-25-081609 4831
2025-06-04 4 4 0000950170-25-081611 5593
2025-06-04 4 4 0000950170-25-081608 4793
2025-05-15 10-Q 10-Q 0000950170-25-072789 001-40908 25954613 34 4607609 1 1
2025-05-15 8-K FORM 8-K 2.02,9.01 0001171843-25-003207 001-40908 25948713 34 252883 1 1
2025-04-30 ARS ARS 0000950170-25-061188 001-40908 25896362 34 1224533
2025-04-30 DEF 14A DEF 14A 0000950170-25-061041 001-40908 25895061 34 2470382
2025-04-18 PRE 14A PRE 14A 0000950170-25-055881 001-40908 25850651 34 1832189
2025-03-18 10-K 10-K 0000950170-25-041379 001-40908 25749361 34 7806963 1 1
2025-03-18 8-K FORM 8-K 2.02,9.01 0001171843-25-001513 001-40908 25746496 34 273210 1 1
2025-03-05 4 4 0000950170-25-033540 4835
2025-03-05 4 4 0000950170-25-033528 4800
2025-03-05 4 4 0000950170-25-033525 5599
2025-03-05 4 4 0000950170-25-033523 4799
2025-03-05 4 4 0000950170-25-033522 4848
2025-01-21 8-K 8-K 5.03,5.07,9.01 0001193125-25-009595 001-40908 25543091 34 173812 1 1
2024-12-20 DEF 14A DEF14A 0001140361-24-050096 001-40908 241568197 34 1714067
2024-12-09 4 4 0000950170-24-134524 7275
2024-12-09 3 3 0000950170-24-134507 3041
2024-12-06 PRE 14A PRE14A 0001140361-24-048693 001-40908 241533155 34 1711502
2024-12-03 4 4 0000950170-24-132525 4802
2024-12-03 4 4 0000950170-24-132524 4851
2024-12-03 4 4 0000950170-24-132520 4803
2024-12-03 4 4 0000950170-24-132518 5603
2024-11-14 10-Q 10-Q 0000950170-24-127033 001-40908 241461884 34 4653335 1 1
2024-11-14 8-K FORM 8-K 2.02,9.01 0001171843-24-006360 001-40908 241457067 34 263809 1 1
2024-10-31 8-K 8-K 5.02,9.01 0000950170-24-119270 001-40908 241412714 34 170131 1 1
2024-10-18 8-K 8-K 5.02 0000950170-24-115596 001-40908 241380784 34 152314 1 1
2024-09-13 8-K 8-K 3.01 0000950170-24-106345 001-40908 241297721 34 153999 1 1
2024-09-05 4 4 0000950170-24-103750 4801
2024-09-05 4 4 0000950170-24-103749 4802
2024-09-05 4 4 0000950170-24-103745 5602
2024-09-05 4 4 0000950170-24-103740 4850
2024-08-30 8-K 8-K 3.01 0000950170-24-102321 001-40908 241269845 34 153426 1 1
2024-08-16 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-08-16 16:00:00 9999999995-24-002571 333-281522 241218147 33 1877
2024-08-16 424B3 424B3 0001193125-24-202168 333-281522 241217227 33 175947
2024-08-15 CORRESP filename1.htm 0001193125-24-201272 6711
2024-08-15 UPLOAD filename1.pdf 0000000000-24-009341 333-281522 40211
2024-08-13 S-3 S-3 0001193125-24-199818 333-281522 241202249 33 298530
2024-08-13 S-8 S-8 0001193125-24-199792 333-281519 241201754 33 71805
2024-08-13 10-Q 10-Q 0000950170-24-096142 001-40908 241201276 34 4754228 1 1
2024-08-13 8-K FORM 8-K 2.02,9.01 0001171843-24-004721 001-40908 241198716 34 274439 1 1
2024-06-17 8-K 8-K 5.07 0000950170-24-074233 001-40908 241048181 34 165022 1 1
2024-06-05 4 4 0000950170-24-069216 4802
2024-06-05 4 4 0000950170-24-069215 4802
2024-06-05 4 4 0000950170-24-069212 5603
2024-06-05 4 4 0000950170-24-069211 4851
2024-05-22 SC 13G GKCC LLC SCHEDULE 13G 0001068238-24-000115 005-92968 24973826 34 34880
2024-05-16 8-K 8-K 1.01,3.02 0000950170-24-060805 001-40908 24953611 34 156202 1 1
2024-05-14 8-K FORM 8-K 2.02,9.01 0001171843-24-002826 001-40908 24941452 34 249474 1 1
2024-05-14 10-Q 10-Q 0000950170-24-059081 001-40908 24941449 34 3868203 1 1
2024-04-30 ARS ARS 0000950170-24-050088 001-40908 24893255 34 1299597
2024-04-29 DEF 14A DEF 14A 0000950170-24-050064 001-40908 24892943 34 1003005
2024-03-21 10-K 10-K 0000950170-24-034672 001-40908 24771299 34 7035514 1 1
2024-03-21 8-K FORM 8-K 2.02,9.01 0001171843-24-001514 001-40908 24769360 34 265055 1 1
2024-03-05 4 4 0000950170-24-026423 4801
2024-03-05 4 4 0000950170-24-026422 4800
2024-03-05 4 4 0000950170-24-026426 5601
2024-03-05 4 4 0000950170-24-026421 4850
2024-02-29 8-K 8-K 3.01 0000950170-24-023061 001-40908 24703536 34 158705 1 1
2024-02-14 SC 13D SC 13D 0001193125-24-036660 005-92968 24641075 34 69328
2024-02-14 8-K 8-K 1.01,2.03 0000950170-24-014944 001-40908 24632425 34 155003 1 1
2024-01-18 4 4 0000950170-24-005561 7940
2024-01-18 4 4 0000950170-24-005562 7938
2023-12-05 4 4 0000950170-23-068322 4719
2023-12-05 4 4 0000950170-23-068313 4769
2023-12-05 4 4 0000950170-23-068312 5520
2023-12-05 4 4 0000950170-23-068311 4720
2023-11-14 10-Q 10-Q 0000950170-23-063851 001-40908 231407980 34 4533093 1 1
2023-11-09 8-K FORM 8-K 2.02,9.01 0001171843-23-006910 001-40908 231389973 34 291126 1 1
2023-10-17 8-K 8-K 5.02 0000950170-23-053752 001-40908 231329758 34 162167 1 1
2023-10-16 4 4 0000950170-23-053601 8348
2023-10-13 4 4 0000950170-23-053381 8155
2023-10-06 4 4 0000950170-23-052408 5174
2023-10-03 4 4 0000950170-23-051760 9194
2023-09-29 4 4 0000950170-23-050807 7016
2023-09-06 4 4 0000950170-23-046777 5233
2023-09-06 4 4 0000950170-23-046776 5284
2023-09-06 4 4 0000950170-23-046775 5232
2023-09-06 4 4 0000950170-23-046774 5232
2023-09-06 4 4 0000950170-23-046773 6031
2023-08-31 4 4 0000950170-23-045816 5175
2023-08-28 4 FORM 4 SUBMISSION 0000899243-23-018546 7173
2023-08-11 S-8 S-8 0001193125-23-209786 333-273906 231161566 33 57763
2023-08-10 8-K FORM 8-K 2.02,9.01 0001171843-23-005189 001-40908 231157181 34 275305 1 1
2023-08-10 10-Q 10-Q 0000950170-23-040958 001-40908 231157179 34 4673037 1 1
2023-06-20 8-K 8-K 5.07 0000950170-23-028900 001-40908 231024888 34 186475 1 1
2023-06-16 4 FORM 4 SUBMISSION 0000899243-23-015852 5431
2023-06-16 4 FORM 4 SUBMISSION 0000899243-23-015849 5430
2023-06-16 4 FORM 4 SUBMISSION 0000899243-23-015843 5479
2023-06-16 4 FORM 4 SUBMISSION 0000899243-23-015839 5431
2023-06-16 4 FORM 4 SUBMISSION 0000899243-23-015837 5338
2023-06-02 4 FORM 4 SUBMISSION 0000899243-23-014415 4995
2023-06-02 4 FORM 4 SUBMISSION 0000899243-23-014414 4945
2023-06-02 4 FORM 4 SUBMISSION 0000899243-23-014412 4945
2023-06-02 4 FORM 4 SUBMISSION 0000899243-23-014410 5745
2023-06-02 4 FORM 4 SUBMISSION 0000899243-23-014409 4945
2023-05-26 4/A 4/A 0000950170-23-024568 4548
2023-05-26 4/A 4/A 0000950170-23-024567 4925
2023-05-26 4/A 4/A 0000950170-23-024556 5962
2023-05-26 SC 13D/A SC 13D/A 0001193125-23-155541 005-92968 23970090 34 48763
2023-05-12 4 4 0000950170-23-021854 6785
2023-05-11 10-Q 10-Q 0000950170-23-021191 001-40908 23910813 34 3982972 1 1
2023-05-11 8-K FORM 8-K 2.02,9.01 0001171843-23-003188 001-40908 23908914 34 250063 1 1
2023-05-05 4 4 0000950170-23-018413 4810
2023-05-05 4 4 0000950170-23-018401 9899
2023-05-04 4 4 0000950170-23-018042 4329
2023-05-03 4 FORM 4 SUBMISSION 0000899243-23-012119 5924
2023-05-03 SC 13D/A SC 13D/A 0001193125-23-134576 005-92968 23885488 34 31171
2023-05-01 DEF 14A DEF 14A 0000950170-23-016187 001-40908 23872945 34 1014920
2023-03-24 10-K 10-K 0000950170-23-009762 001-40908 23760539 34 8011317 1 1
2023-03-21 8-K FORM 8-K 2.02,9.01 0001171843-23-001783 001-40908 23747871 34 277521 1 1
2023-03-03 4 FORM 4 SUBMISSION 0000899243-23-006928 5672
2023-03-03 4 FORM 4 SUBMISSION 0000899243-23-006922 4963
2023-03-03 4 FORM 4 SUBMISSION 0000899243-23-006915 4914
2023-03-03 4 FORM 4 SUBMISSION 0000899243-23-006913 4913
2023-03-03 4 FORM 4 SUBMISSION 0000899243-23-006912 4914
2023-01-18 4 FORM 4 SUBMISSION 0000899243-23-001964 5520
2023-01-12 4 FORM 4 SUBMISSION 0000899243-23-001660 6955
2023-01-11 4 FORM 4 SUBMISSION 0000899243-23-001622 5664
2023-01-11 4 FORM 4 SUBMISSION 0000899243-23-001620 7809
2022-12-05 4 FORM 4 SUBMISSION 0000899243-22-037698 5977
2022-12-05 4 FORM 4 SUBMISSION 0000899243-22-037655 4915
2022-12-05 4 FORM 4 SUBMISSION 0000899243-22-037653 5156
2022-12-05 4 FORM 4 SUBMISSION 0000899243-22-037650 4914
2022-12-05 4 FORM 4 SUBMISSION 0000899243-22-037646 4915
2022-11-08 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-11-08 16:00:00 9999999995-22-003237 333-268143 221370499 33 1828
2022-11-07 CORRESP filename1.htm 0001193125-22-278982 6859
2022-11-07 UPLOAD filename1.pdf 0000000000-22-012111 40374
2022-11-03 S-3 S-3 0001193125-22-277009 333-268143 221359019 33 718877
2022-11-03 8-K FORM 8-K 2.02,9.01 0001171843-22-007046 001-40908 221356324 34 272636 1 1
2022-11-03 10-Q 10-Q 0000950170-22-021565 001-40908 221356295 34 4654249 1 1
2022-09-19 4 FORM 4 SUBMISSION 0000899243-22-031534 4916
2022-09-19 4 FORM 4 SUBMISSION 0000899243-22-031528 4823
2022-09-19 4 FORM 4 SUBMISSION 0000899243-22-031530 4916
2022-09-19 4 FORM 4 SUBMISSION 0000899243-22-031529 4915
2022-09-19 4 FORM 4 SUBMISSION 0000899243-22-031523 4964
2022-08-15 10-Q 10-Q 0001564590-22-029503 001-40908 221166780 34 4234122 1 1
2022-08-09 8-K FORM 8-K 2.02,9.01 0001171843-22-005501 001-40908 221146463 34 275649 1 1
2022-08-05 8-K 8-K 1.01 0001193125-22-213655 001-40908 221141294 34 149543 1 1
2022-07-21 4 FORM 4 SUBMISSION 0000899243-22-026460 6771
2022-07-15 S-8 S-8 0001193125-22-195031 333-266170 221087369 33 95859
2022-06-14 8-K 8-K 5.02,5.07,9.01 0001193125-22-173902 001-40908 221015549 34 235574 1 1
2022-05-13 10-Q 10-Q 0001564590-22-020146 001-40908 22923472 34 3194780 1 1
2022-05-10 8-K FORM 8-K 2.02,9.01 0001171843-22-003482 001-40908 22907438 34 243823 1 1
2022-04-29 DEF 14A DEF 14A 0001193125-22-133970 001-40908 22876227 34 653566
2022-03-18 10-K 10-K 0001564590-22-011026 001-40908 22752011 34 8811135 1 1
2022-03-11 4 FORM 4 SUBMISSION 0000899243-22-010708 5398
2022-03-11 4 FORM 4 SUBMISSION 0000899243-22-010706 5394
2022-03-11 4 FORM 4 SUBMISSION 0000899243-22-010704 5397
2022-03-11 4 FORM 4 SUBMISSION 0000899243-22-010700 5446
2022-03-11 4 FORM 4 SUBMISSION 0000899243-22-010698 5305
2022-03-08 8-K 8-K 5.02 0001193125-22-069441 001-40908 22722886 34 151068 1 1
2022-02-14 SC 13G SC 13G 0001193125-22-041640 005-92968 22631493 34 39820
2022-02-14 5 FORM 5 SUBMISSION 0000899243-22-006140 4885
2022-01-25 4 FORM 4 SUBMISSION 0000899243-22-003172 5681
2022-01-25 4 FORM 4 SUBMISSION 0000899243-22-003171 5649
2022-01-06 8-K 8-K 5.02 0001193125-22-003536 001-40908 22514825 34 145605 1 1
2021-11-29 10-Q 10-Q 0001564590-21-058700 001-40908 211457237 34 4674260 1 1
2021-10-28 SC 13D SC 13D 0001193125-21-311369 005-92968 211358754 34 260318
2021-10-20 4 FORM 4 SUBMISSION 0000899243-21-040873 9272
2021-10-20 3 FORM 3 SUBMISSION 0000899243-21-040865 11392
2021-10-20 3 FORM 3 SUBMISSION 0000899243-21-040864 5335
2021-10-20 3 FORM 3 SUBMISSION 0000899243-21-040861 8269
2021-10-20 3 FORM 3 SUBMISSION 0000899243-21-040860 10265
2021-10-20 3 FORM 3 SUBMISSION 0000899243-21-040858 11248
2021-10-20 3 FORM 3 SUBMISSION 0000899243-21-040857 8261
2021-10-20 3 FORM 3 SUBMISSION 0000899243-21-040856 13013
2021-10-20 3 FORM 3 SUBMISSION 0000899243-21-040854 7674
2021-10-20 3 FORM 3 SUBMISSION 0000899243-21-040850 8270
2021-10-20 3 FORM 3 SUBMISSION 0000899243-21-040849 11633
2021-10-20 3 FORM 3 SUBMISSION 0000899243-21-040845 13316
2021-10-20 8-K 8-K 3.03,5.03,9.01 0001193125-21-303045 001-40908 211334110 34 113681
2021-10-15 424B4 424B4 0001193125-21-300184 333-259503 211326818 33 2657640
2021-10-15 FWP FWP 0001193125-21-299060 333-259503 211324588 34 10119
2021-10-14 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-10-14 16:00:00 9999999995-21-003881 333-259503 211324696 33 1802
2021-10-14 CERT 8A_Cert_INKT.pdf 0001354457-21-001157 001-40908 211322640 34 214458
2021-10-13 8-A12B 8-A12B 0001193125-21-297781 001-40908 211321257 34 14259
2021-10-12 CORRESP filename1.htm 0001193125-21-296972 8051
2021-10-12 CORRESP filename1.htm 0001193125-21-296966 6118
2021-10-12 S-1/A S-1/A 0001193125-21-296215 333-259503 211316690 33 3922346
2021-09-24 CORRESP filename1.htm 0001193125-21-282464 45857
2021-09-14 S-1 S-1 0001193125-21-271914 333-259503 211251071 33 3385897
2021-09-13 CORRESP filename1.htm 0001193125-21-271924 17627
2021-08-12 UPLOAD filename1.pdf 0000000000-21-009866 43811
2021-07-28 DRSLTR filename1.htm 0000950123-21-009294 17581
2021-07-28 DRS/A filename1.htm 0000950123-21-009292 377-04074 211123721 33 2522047
2021-04-01 UPLOAD filename1.pdf 0000000000-21-003906 44783
2021-03-18 DRS/A filename1.htm 0000950123-21-003599 377-04074 21752858 33 2592849
2021-03-17 DRSLTR filename1.htm 0000950123-21-003600 74763
2021-02-22 UPLOAD filename1.pdf 0000000000-21-002119 70889
2021-01-22 DRS filename1.htm 0000950123-21-000524 377-04074 21545926 33 2474649

Latest XBRL company facts

One latest value per concept from companyfacts (166 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 5.13M 2026-11-06 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
dei EntityPublicFloat Entity Public Float USD 10.90M 2025-06-30 2025 FY 10-K 2026-03-31 0001193125-26-134813
ffd NetFeeAmt NetFeeAmt USD 365.59 2026-08-13 S-8 2026-08-13 0001193125-26-349328
ffd TtlFeeAmt TtlFeeAmt USD 365.59 2026-08-13 S-8 2026-08-13 0001193125-26-349328
ffd TtlOfferingAmt TtlOfferingAmt USD 2.65M 2026-08-13 S-8 2026-08-13 0001193125-26-349328
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-13 S-8 2026-08-13 0001193125-26-349328
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 4.49M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.32M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 635,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 634,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 719,926 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -704,156 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 149.55M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 8,079 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap Assets Assets USD 8.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap AssetsCurrent Assets, Current USD 7.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap Cash Cash USD 38.89M 2021-12-31 2021 FY 10-K 2022-03-18 0001564590-22-011026
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 7.47M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 7.47M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -5.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 150.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 5.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 5.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap CommonStockValue Common Stock, Value, Issued USD 52 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -8.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 5.45M 2021-10-01 2021-10-31 2022 FY 10-K 2023-03-24 0000950170-23-009762
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 43.82M 2020-12-31 2021 FY 10-K 2022-03-18 0001564590-22-011026
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 65.42M 2021-09-30 2021 Q3 10-Q 2021-11-29 0001564590-21-058700
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 5.00M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap DeconsolidationGainOrLossAmount Deconsolidation, Gain (Loss), Amount USD 185,351 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 539,000 2020-12-31 2021 FY 10-K 2022-03-18 0001564590-22-011026
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 31.74M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 5.28M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 19.36M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 4.78M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1.48M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 479,000 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 31.74M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 93,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap Depreciation Depreciation USD 108,195 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 5.95M 2021-12-31 2022 FY 10-K 2023-03-24 0000950170-23-009762
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 9.72M 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021191
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.69 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.23 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0001564590-22-020146
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.69 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -7,050 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 600,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 1.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -14,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-24 0000950170-23-009762
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -169,291 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001193125-25-282905
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 355,515 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-24 0000950170-23-009762
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 4.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 476,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 737,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 286,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-21 0000950170-24-034672
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -2.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -350,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -942,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 3.42M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-24 0000950170-23-009762
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -194,371 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-18 0001564590-22-011026
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD -2,772 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD -847,277 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 71,453 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap InsuranceSettlementsReceivableCurrent Insurance Settlements Receivable, Current USD 234,000 2020-12-31 2021 FY 10-K 2022-03-18 0001564590-22-011026
us-gaap InterestExpense Interest Expense USD -7,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 226,040 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 7,213 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap LaborAndRelatedExpense Labor and Related Expense USD -2.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 8.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap LiabilitiesCurrent Liabilities, Current USD 8.18M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -734,676 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -56,716 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -5.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -8.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -8.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 70.80M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 15,000 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108894
us-gaap OtherAssetsCurrent Other Assets, Current USD 85,152 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 14,760 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -4,264 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap OtherCostAndExpenseOperating Other Cost and Expense, Operating USD 1.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap OtherExpenses Other Expenses USD 80,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0000950170-25-072789
us-gaap OtherIncome Other Income USD 331,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0000950170-25-041379
us-gaap OtherLiabilities Other Liabilities USD 29,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349309
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 2.37M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-18 0000950170-25-041379
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 87,051 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 6.20M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-24 0000950170-23-009762
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 56,716 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 347,884 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 39.80M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-24 0000950170-23-009762
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 355,515 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-18 0001564590-22-011026
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 5.80M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 4.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ProceedsFromLoans Proceeds from Loans USD 356,000 2020-05-01 2020-05-31 2022 FY 10-K 2023-03-24 0000950170-23-009762
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1,595 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-24 0000950170-23-009762
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -8.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.00M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 339,160 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 5.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 4.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -165.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested USD 801,257 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 1,218 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 11.09 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 88,179 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 11.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 77,969 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 11.43 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 86,858 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 11.31 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.07 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.039 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 4.54M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 691,133 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6.28 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 797,971 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 1,443 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 25,277 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 64,288 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 12.97 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 5.04M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 894,959 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 7.28 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 5.04M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 894,959 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 7.28 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 6.86 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 7.22 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 7.41 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 15.36 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap SharesPaidForTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation shares 22,641 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -16.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.1 2025-01-28 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap StockIssued1 Stock Issued USD 1.01M 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-127033
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 5.45M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-24 0000950170-23-009762
us-gaap StockIssuedDuringPeriodSharesEmployeeBenefitPlan Stock Issued During Period, Shares, Employee Benefit Plan shares 65,917 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 20,941 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 19,142 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 65.42M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-24 0000950170-23-009762
us-gaap StockIssuedDuringPeriodValueEmployeeBenefitPlan Stock Issued During Period, Value, Employee Benefit Plan USD 481,229 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 576 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 22,000 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 1.37M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures Stock Issued During Period, Value, Restricted Stock Award, Forfeitures USD 75 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-21 0000950170-24-034672
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 540 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 0 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-18 0000950170-25-041379
us-gaap TreasuryStockRetiredCostMethodAmount Treasury Stock, Retired, Cost Method, Amount USD 477,637 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-18 0000950170-25-041379
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134813
us-gaap ValueAddedTaxReceivableCurrent Value Added Tax Receivable, Current USD 23,000 2021-12-31 2021 FY 10-K 2022-03-18 0001564590-22-011026
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 4.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 33.50M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0001564590-22-020146
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 4.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457280

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →